Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03829462
Title Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients (NEXT-REGIRI)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Institut du Cancer de Montpellier - Val d'Aurelle
Indications

colon adenocarcinoma

colorectal cancer

rectum adenocarcinoma

Therapies

Regorafenib

Irinotecan + Regorafenib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.